Results summary | View all lists in GO:BiolProc | View all genes in S01C.profile.ud50 |
A biological process whose specific outcome is the progression of an integrated living unit: a cell, tissue, organ, or organism over time from an initial condition to a later condition. enrichment: 1.66-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
212849_AT | AXIN1 | G | D | P | S | axin 1 | |||||||
201107_S_AT | THBS1 | D | X | C | thrombospondin 1 | ||||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
219657_S_AT | KLF3 | D | R | Kruppel-like factor 3 (basic) | |||||||||
213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
217997_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
213552_AT | GLCE | E | P | glucuronic acid epimerase | |||||||||
202923_S_AT | GCLC | G | X | E | R | glutamate-cysteine ligase, catalytic subunit | |||||||
214439_X_AT | BIN1 | G | T | D | bridging integrator 1 | ||||||||
205945_AT | IL6R | G | D | X | S | interleukin 6 receptor | |||||||
213179_AT | RQCD1 | RCD1 required for cell differentiation1 homolog (S. pombe) | |||||||||||
215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
203358_S_AT | EZH2 | D | P | R | enhancer of zeste homolog 2 (Drosophila) | ||||||||
203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
46665_AT | SEMA4C | D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C | ||||||||||
204999_S_AT | ATF5 | G | R | activating transcription factor 5 | |||||||||
212593_S_AT | PDCD4 | G | R | programmed cell death 4 (neoplastic transformation inhibitor) | |||||||||
205655_AT | MDM4 | G | P | R | Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse) | ||||||||
211082_X_AT | MARK2 | D | P | S | MAP/microtubule affinity-regulating kinase 2 | ||||||||
200797_S_AT | MCL1 | G | D | S | myeloid cell leukemia sequence 1 (BCL2-related) | ||||||||
222152_AT | PDCD6 | G | programmed cell death 6 | ||||||||||
200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
205409_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
209120_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
201340_S_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
207023_X_AT | KRT10 | D | keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) | ||||||||||
211833_S_AT | BAX | G | T | D | X | P | S | BCL2-associated X protein |